Weaxen
Product
PricingSecurityCommunity
Viewing for
πŸ‡¬πŸ‡§UKπŸ‡¦πŸ‡ͺUAEπŸ‡ΊπŸ‡ΈUS
Healthcare & Life Sciences Β· UK

When the user is a patient, β€œmove fast and break things” was never an option.

Digital health teams live between two cultures: clinicians who demand evidence-grade rationale and software teams who ship weekly. Weaxen serves both β€” the research depth and structured risk clinical stakeholders expect, and a way to keep learning from the product once it's live, without slowing the build.

Get Started

Why product decisions are harder here

Clinical stakeholders don't accept vibes

A roadmap argument that works in consumer SaaS dies in a clinical safety review. Clinicians, safety officers, and medical directors expect real evidence β€” literature, users, clinical reality β€” weighed and cited, not a confident opinion. Getting to that depth is the work most teams underestimate.

Clinical safety is a living case

Under DCB0129/0160-style clinical risk management, a product's hazards, mitigations, and intended use must be documented and kept current as it evolves β€” for the MHRA where it's a medical device, and for every trust that deploys it. Retrofitting that case is where programmes go to die.

Long cycles, moving teams

Health products take years to reach scale, and the clinician or PM who framed the original intent may be gone by the time they do. When intended purpose and risk rationale live in people, every departure is a small programme reset.

How we can help

Without Weaxen

  • Product rationale that satisfies engineers but collapses in front of a clinical safety officer
  • Evidence gathered once and frozen at launch β€” no mechanism to learn from real-world use
  • Clinical-safety and intended-use documentation retrofitted under deadline, long after the decisions
  • Context resetting every time a clinical lead, PM, or supplier rotates off the programme

With Weaxen

  • Deep, cited research β€” clinical, user, and market β€” that stands up to a safety review
  • A learning loop that turns real-world signals into the evidence for the next iteration
  • Intended purpose, population, and hazards captured as decisions are made and kept current
  • Governance and lineage that survive the multi-year journey, whoever is on the team

Here's how it works

Get Started
01

Brief the initiative

Teams describe what they're building in plain language. No taxonomy to learn, no template to fill.

02

Weaxen runs the framework

Path Forger recommends the right artefacts for your stage and risk level. A scrappy pre-seed run looks different to a Series A launch β€” same engine, right dose.

03

Leave with a Project Kit

Every decision documented. Every assumption surfaced. Every risk traceable. Ready for engineers, boards, or Claude Code.

Get Started

Questions teams ask us

Does Weaxen store patient data?

No. Weaxen holds your product research, strategy, and decision records β€” not patient records or clinical data. Your workspace content is encrypted in transit and at rest and held in the UK (AWS London region) by default, with on-soil options where residency is required.

Can it handle our clinical governance process?

RACI and phase sign-off are built into the framework, and every artefact is versioned with its evidence attached β€” which maps naturally onto clinical safety (DCB0129/0160) and quality-management reviews.

We work with NHS bodies. Does that change anything?

The decision-trail discipline Weaxen enforces is exactly what NHS procurement, DTAC, and information-governance processes ask for. For specific requirements, talk to us early β€” security documentation is available on request.

How fast can a team start?

Self-serve, same day. Bring one initiative heading for a safety or governance review and run it through the framework β€” the documentation burden is where teams feel the difference first.

Bring a real initiative. Leave with a real Project Kit.

For teams who treat "build the right thing" as a precondition, not a slogan. Start for free β†’

Get StartedSee Community Projects